Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Raymond Yi-kun Huang"'
Publikováno v:
Frontiers in Neurology, Vol 6 (2015)
Glioblastoma, the most common malignant primary brain tumor in adults is a devastating diagnosis with an average survival of 14-16 months using the current standard of care treatment. The determination of treatment response and clinical decision maki
Externí odkaz:
https://doaj.org/article/30d003601f944caa853cf7f311ccc94a
Autor:
Mishka Gidwani, Ken Chang, Jay Biren Patel, Albert Eusik Kim, Elizabeth R. Gerstner, Raymond Yi-kun Huang, Jayashree Kalpathy-Cramer
Publikováno v:
Journal of Clinical Oncology. 40:e14003-e14003
e14003 Background: The Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) is the standard for therapeutic response assessment in brain metastases (BM) patients. The criteria relies on a human reader to annotate target (≥10 mm) and
Autor:
Gilbert Youssef, Rifaquat Rahman, Mary Jane Lim-Fat, Camden Bay, Wenya Linda L. Bi, Daniel Cagney, YuhShin Chang, Matthew Nicholas Desalvo, Thomas Flood, Elizabeth R. Gerstner, Luis Nicolas Gonzalez Castro, Jeffrey Guenette, Albert Eusik Kim, Eudocia Quant Lee, J. Ricardo Ricardo McFaline Figueroa, Christopher Potter, David A. Reardon, Benjamin M. Ellingson, Raymond Yi-kun Huang, Patrick Y. Wen
Publikováno v:
Journal of Clinical Oncology. 40:2020-2020
2020 Background: The Response Assessment in Neuro-Oncology (RANO) and modified RANO (mRANO) criteria are the two most widely used criteria to evaluate treatment response in glioblastoma (GBM) clinical trials. Unlike RANO, mRANO omits the evaluation o